Cellular and molecular medicine is expanding its clinical role from day to day. Personalized medicine seems the appropraite response for many unresolved problem and this is why we could rely on this approach more than before. Integrating the techniques of cellular and molecular medicine to our daily anesthesia practice improves not only the quality of care; but also, opens new windows for overcoming challenges that were previously considered as unaccessible fields.
Dabbagh A, Rajaei S, Golzari SE. History of anesthesia and pain in old Iranian texts. Anesth Pain Med. 2014;4(3):e15363.
Wiederhold BK, Soomro A, Riva G, Wiederhold MD. Future directions: advances and implications of virtual environments designed for pain management. Cyberpsychology, behavior and social networking. 2014;17(6):414-22.
Popping DM, Zahn PK, Van Aken HK, Dasch B, Boche R, Pogatzki-Zahn EM. Effectiveness and safety of postoperative pain management: a survey of 18 925 consecutive patients between 1998 and 2006 (2nd revision): a database analysis of prospectively raised data. Br J Anaesth. 2008;101(6):832-40.
Matsumura Y, Yamashita T, Sasaki A, Nakata E, Kohno K, Masuda T, et al. A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain. Scientific reports. 2016;6:32461.
Rajaei S DA. The molecular mechanisms of Vitamin D effects on alleviating premenstrual syndrome pain. J Cell Mol Anesth. 2017;2(1):30-6.
Dabbagh A. Microglial Cells: the Bridge Between the Immune System and Pain in the Central Nervous System. J Cell Mol Anesth. 2016;1(4):135-6.
Talebi Z DA. Perioperative Pain: Molecular Mechanisms and Future Perspectives. J Cell Mol Anesth. 2017;2(3):134-41.
Dorgalaleh A MH, Tabibian Sh. Majid N. Burden of Congenital Factor XIII Deficiency in Iran. J Cell Mol Anesth. 2017;2(3):142-5.
Naderi M TS, Alizadeh S, Dorgalaleh A. Coagulation factor XIII-a tyr204phe gene variation shows ethnic heterogeneity, an Iranian based study. J Cell Mol Anesth. 2016;1(1):19-22.
Bamedi T DG, Sarabandi A, Tabibian S, Shams M, Dorgalaleh A. Genetic Risk Factors for Inhibitor Development in Patients with Hemophilia and Rare Bleeding Disorders. J Cell Mol Anesth. 2017;2(1):19-23.